385 related articles for article (PubMed ID: 31281853)
1. High Thymic Output of Effector CD4
Zhao Y; Alard P; Kosiewicz MM
J Immunol Res; 2019; 2019():8785263. PubMed ID: 31281853
[TBL] [Abstract][Full Text] [Related]
2. Thymically-derived Foxp3+ regulatory T cells are the primary regulators of type 1 diabetes in the non-obese diabetic mouse model.
Holohan DR; Van Gool F; Bluestone JA
PLoS One; 2019; 14(10):e0217728. PubMed ID: 31647813
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid hormone differentially modulates the in vitro expansion and cytokine profile of thymic and splenic Treg cells.
Pap R; Ugor E; Litvai T; Prenek L; Najbauer J; Németh P; Berki T
Immunobiology; 2019 Mar; 224(2):285-295. PubMed ID: 30612787
[TBL] [Abstract][Full Text] [Related]
4. Enhanced thymic selection of FoxP3+ regulatory T cells in the NOD mouse model of autoimmune diabetes.
Feuerer M; Jiang W; Holler PD; Satpathy A; Campbell C; Bogue M; Mathis D; Benoist C
Proc Natl Acad Sci U S A; 2007 Nov; 104(46):18181-6. PubMed ID: 17991775
[TBL] [Abstract][Full Text] [Related]
5. Surge in regulatory T cells does not prevent onset of hyperglycemia in NOD mice: immune profiles do not correlate with disease severity.
Kaminitz A; Mizrahi K; Askenasy N
Autoimmunity; 2014 Mar; 47(2):105-12. PubMed ID: 24328490
[TBL] [Abstract][Full Text] [Related]
6. Impact of protective IL-2 allelic variants on CD4+ Foxp3+ regulatory T cell function in situ and resistance to autoimmune diabetes in NOD mice.
Sgouroudis E; Albanese A; Piccirillo CA
J Immunol; 2008 Nov; 181(9):6283-92. PubMed ID: 18941219
[TBL] [Abstract][Full Text] [Related]
7. Peripherally induced regulatory T cells contribute to the control of autoimmune diabetes in the NOD mouse model.
Schuster C; Jonas F; Zhao F; Kissler S
Eur J Immunol; 2018 Jul; 48(7):1211-1216. PubMed ID: 29604048
[TBL] [Abstract][Full Text] [Related]
8. Induction of Foxp3 demethylation increases regulatory CD4+CD25+ T cells and prevents the occurrence of diabetes in mice.
Zheng Q; Xu Y; Liu Y; Zhang B; Li X; Guo F; Zhao Y
J Mol Med (Berl); 2009 Dec; 87(12):1191-205. PubMed ID: 19841877
[TBL] [Abstract][Full Text] [Related]
9. Type 1 Diabetes Brazilian patients exhibit reduced frequency of recent thymic emigrants in regulatory CD4
Nogueira JS; Gomes TR; Secco DA; de Almeida IS; da Costa ASMF; Cobas RA; Costa Dos Santos G; Gomes MB; Porto LC
Immunol Lett; 2024 Jun; 267():106857. PubMed ID: 38604551
[TBL] [Abstract][Full Text] [Related]
10. Induction of self-antigen-specific Foxp3+ regulatory T cells in the periphery by lymphodepletion treatment with anti-mouse thymocyte globulin in mice.
Lu Y; Suzuki J; Guillioli M; Umland O; Chen Z
Immunology; 2011 Sep; 134(1):50-9. PubMed ID: 21711461
[TBL] [Abstract][Full Text] [Related]
11. IL-2 promotes the function of memory-like autoregulatory CD8+ T cells but suppresses their development via FoxP3+ Treg cells.
Shameli A; Yamanouchi J; Tsai S; Yang Y; Clemente-Casares X; Moore A; Serra P; Santamaria P
Eur J Immunol; 2013 Feb; 43(2):394-403. PubMed ID: 23180662
[TBL] [Abstract][Full Text] [Related]
12. Thymic development of autoreactive T cells in NOD mice is regulated in an age-dependent manner.
He Q; Morillon YM; Spidale NA; Kroger CJ; Liu B; Sartor RB; Wang B; Tisch R
J Immunol; 2013 Dec; 191(12):5858-66. PubMed ID: 24198282
[TBL] [Abstract][Full Text] [Related]
13. PI3Kγ Deficient NOD-Mice Are Protected from Diabetes by Restoring the Balance of Regulatory to Effector-T-Cells.
Azzi J; Thueson L; Moore R; Abdoli R; Reijonen H; Abdi R
PLoS One; 2017; 12(1):e0169695. PubMed ID: 28081180
[TBL] [Abstract][Full Text] [Related]
14. Differences in T regulatory cells between mouse strains frequently used in immunological research: Treg cell quantities and subpopulations in NOD, B6 and BALB/c mice.
Godoy GJ; Paira DA; Olivera C; Breser ML; Sanchez LR; Motrich RD; Rivero VE
Immunol Lett; 2020 Jul; 223():17-25. PubMed ID: 32330480
[TBL] [Abstract][Full Text] [Related]
15. Transient Depletion of Foxp3
Watts D; Janßen M; Jaykar M; Palmucci F; Weigelt M; Petzold C; Hommel A; Sparwasser T; Bonifacio E; Kretschmer K
Front Immunol; 2021; 12():720133. PubMed ID: 34447385
[TBL] [Abstract][Full Text] [Related]
16. T Regulatory Cells From Non-obese Diabetic Mice Show Low Responsiveness to IL-2 Stimulation and Exhibit Differential Expression of Anergy-Related and Ubiquitination Factors.
Godoy GJ; Olivera C; Paira DA; Salazar FC; Ana Y; Stempin CC; Motrich RD; Rivero VE
Front Immunol; 2019; 10():2665. PubMed ID: 31824482
[TBL] [Abstract][Full Text] [Related]
17. Functional waning of naturally occurring CD4+ regulatory T-cells contributes to the onset of autoimmune diabetes.
Tritt M; Sgouroudis E; d'Hennezel E; Albanese A; Piccirillo CA
Diabetes; 2008 Jan; 57(1):113-23. PubMed ID: 17928397
[TBL] [Abstract][Full Text] [Related]
18. Thymic commitment of regulatory T cells is a pathway of TCR-dependent selection that isolates repertoires undergoing positive or negative selection.
Coutinho A; Caramalho I; Seixas E; Demengeot J
Curr Top Microbiol Immunol; 2005; 293():43-71. PubMed ID: 15981475
[TBL] [Abstract][Full Text] [Related]
19. Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells.
Brode S; Raine T; Zaccone P; Cooke A
J Immunol; 2006 Nov; 177(10):6603-12. PubMed ID: 17082572
[TBL] [Abstract][Full Text] [Related]
20. Reduced IL-2 expression in NOD mice leads to a temporal increase in CD62Llo FoxP3+ CD4+ T cells with limited suppressor activity.
Goudy KS; Johnson MC; Garland A; Li C; Samulski RJ; Wang B; Tisch R
Eur J Immunol; 2011 May; 41(5):1480-1490. PubMed ID: 21469091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
